Gelteq Ltd SEC filings GELS
Gelteq Ltd has 72 filings in SEC EDGAR's recent list, going back to Mar 31, 2022. Its latest annual report, Form 20-F, was filed on Nov 17, 2025 for the period ended Jun 30, 2025. The most recent current report (Form 6-K) was filed on Jul 6, 2026. The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| NT 20-F | Notification of late filing | Nov 2, 2026 | Jun 30, 2026 |
| NT 20-F | Notification of late filing | Nov 3, 2025 | Jun 30, 2025 |
| EFFECT | Filing | Aug 29, 2025 | — |
| CORRESP | Letter to the SEC | Aug 28, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 8, 2025 | — |
| NT 20-F | Notification of late filing | Oct 31, 2024 | Jun 30, 2024 |
| CERT | Filing | Oct 28, 2024 | — |
| 8-A12B | For registration of certain classes | Oct 17, 2024 | — |
| EFFECT | Filing | Sep 30, 2024 | — |
| CORRESP | Letter to the SEC | Sep 26, 2024 | — |
| CORRESP | Letter to the SEC | Sep 26, 2024 | — |
| CORRESP | Letter to the SEC | Sep 24, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 20, 2024 | — |
| CORRESP | Letter to the SEC | Sep 12, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 24, 2024 | — |
| RW | Registration withdrawl request | Jul 15, 2024 | — |
| AW | Withdrawal of amendment registration statement | Jul 15, 2024 | — |
| SEC STAFF LETTER | Filing | Apr 4, 2024 | — |
| EFFECT | Filing | Mar 29, 2024 | — |
| CORRESP | Letter to the SEC | Mar 27, 2024 | — |
| CORRESP | Letter to the SEC | Mar 27, 2024 | — |
| CORRESP | Letter to the SEC | Dec 5, 2023 | — |
| UPLOAD | Letter from the SEC | Sep 25, 2023 | — |
| CORRESP | Letter to the SEC | Sep 15, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 30, 2023 | — |
| CORRESP | Letter to the SEC | Mar 29, 2023 | — |
| SEC STAFF LETTER | Filing | Mar 27, 2023 | — |
| UPLOAD | Letter from the SEC | Mar 27, 2023 | — |
| CORRESP | Letter to the SEC | Mar 17, 2023 | — |
| UPLOAD | Letter from the SEC | Feb 21, 2023 | — |
| CORRESP | Letter to the SEC | Feb 3, 2023 | — |
| UPLOAD | Letter from the SEC | Dec 28, 2022 | — |
| CORRESP | Letter to the SEC | Dec 9, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 19, 2022 | — |
| CORRESP | Letter to the SEC | Aug 30, 2022 | — |
| UPLOAD | Letter from the SEC | Jul 21, 2022 | — |
| DRSLTR | Filing | Jun 30, 2022 | — |
| DRS/A | Filing | Jun 30, 2022 | — |
| UPLOAD | Letter from the SEC | Apr 28, 2022 | — |
| DRS | Filing | Mar 31, 2022 | — |
Showing 40 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- GELS (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- Australia
- Headquarters
- South Melbourne Vic
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1920092
- Former names
- Gelteq Pty Ltd. (until Mar 31, 2022)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.